The statistic shows the operating revenue of the active pharmaceutical ingredient (API) processing market in China from 2013 to 2019. In 2019, the active pharmaceutical ingredient processing industry in China had generated a revenue of about 380 billion yuan.
Operating revenue from the active pharmaceutical ingredient (API) manufacturing in China from 2013 to 2019 (in billion yuan)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Operating revenue of the sanitary and medical product market in China 2013-2019
- Revenue of LBF worldwide 2013-2015
- Operating revenue of the Chinese herbal decoction piece market in China 2013-2019
- Towa Pharmaceutical's profit FY 2012-2017
- Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
- Share of global pharmaceutical gross value added by product type 2012
- Global pharmaceutical industry by wages and salaries per employee 2006-2014
- Production in European pharmaceutical industry by country 2018
- Mexico: pharmaceutical production 2017-2022
- Global pharmaceutical industry by growth rate of salaries per employee 2006-2012
- Market value of pharmaceutical industry by European country 2018
- Brazil: pharmaceutical industry revenue 2008-2018
- Towa Pharmaceutical's sales revenue FY 2012-2017
- Global pharmaceutical gross value added by product type 2012
- Global pharmaceutical industry by growth rate in wages and salaries 2006-2014
- Most valuable Chinese private healthcare enterprises 2020
- Preferred mobile communication methods South Korea 2020, by age
- Real transportation consumer spending per capita forecast in Laos 2010-2025
- Real transportation consumer spending per capita forecast in Thailand 2010-2025
- Real household upkeep consumer spending forecast in Iraq 2010-2025
National Bureau of Statistics of China. (June 1, 2020). Operating revenue from the active pharmaceutical ingredient (API) manufacturing in China from 2013 to 2019 (in billion yuan) [Graph]. In Statista. Retrieved January 19, 2021, from https://www.statista.com/statistics/450451/active-pharmaceutical-ingredient-market-in-china-operating-revenue/
National Bureau of Statistics of China. "Operating revenue from the active pharmaceutical ingredient (API) manufacturing in China from 2013 to 2019 (in billion yuan)." Chart. June 1, 2020. Statista. Accessed January 19, 2021. https://www.statista.com/statistics/450451/active-pharmaceutical-ingredient-market-in-china-operating-revenue/
National Bureau of Statistics of China. (2020). Operating revenue from the active pharmaceutical ingredient (API) manufacturing in China from 2013 to 2019 (in billion yuan). Statista. Statista Inc.. Accessed: January 19, 2021. https://www.statista.com/statistics/450451/active-pharmaceutical-ingredient-market-in-china-operating-revenue/
National Bureau of Statistics of China. "Operating Revenue from The Active Pharmaceutical Ingredient (Api) Manufacturing in China from 2013 to 2019 (in Billion Yuan)." Statista, Statista Inc., 1 Jun 2020, https://www.statista.com/statistics/450451/active-pharmaceutical-ingredient-market-in-china-operating-revenue/
National Bureau of Statistics of China, Operating revenue from the active pharmaceutical ingredient (API) manufacturing in China from 2013 to 2019 (in billion yuan) Statista, https://www.statista.com/statistics/450451/active-pharmaceutical-ingredient-market-in-china-operating-revenue/ (last visited January 19, 2021)